Uneven organ aging linked to higher death risk in UK cohort
Higher imbalance was linked to greater mortality risk, with a relative-risk measure called a hazard ratio of 1.11 per standard-deviation increase.

Our read
Biomarkers- Studied:
- Preprint: cohort study of 221,599 UK Biobank participants (Independent replication)
- What changed:
- Death risk was higher with more uneven organ aging (hazard ratio of 1.11 per standard-deviation increase)
- The catch:
- Existing health differences could contribute to both uneven organ aging and later death
Editor of record: Boris Djordjevic · AgingResearch.News
Among 221,599 UK Biobank participants, an observational analysis examined differences in biological aging across six organ systems. The researchers put measures of biological aging on a common scale, then calculated how widely they differed across organs within each person. A standard deviation describes the spread of scores.
Greater imbalance was associated with a higher risk of death after accounting for overall biological aging, chronological age and sex. It was also linked to six new organ-disease outcomes and three transitions involving multiple diseases. The mortality association persisted even among people with relatively low overall biological aging, with a hazard ratio of 1.09. The researchers validated the mortality associations in five external cohorts.
Why it matters
Organs can differ in their biological aging. The authors suggest that considering these differences alongside overall biological age may offer a fuller view of vulnerability to illness and death.
Caveats
Existing health differences could have contributed both to uneven organ aging and to later illness or death. The findings come from a preprint that has not been peer-reviewed.
Where the evidence stands
Amino acid metabolism
- 57 independent labs in 19 countries
- 2 findings against
- Funders: National Institutes of Health and others
- 10 of 65 findings with company ties
DNA repair
- 124 independent labs in 27 countries
- 5 findings against
- 1 trial
- Funders: National Institutes of Health and others
- 25 of 192 findings with company ties
- 1 of 1 trial sponsored by developers of drugs aimed at it
The paper
Beyond accelerated aging: Multi-organ aging imbalance predicts adverse health outcomes
Fudan University
Research Square, Nov 9, 2026, Open access, Preprint, not yet peer-reviewed



Comments
Be the first to comment.